Login to Your Account

Pharma: Other News To Note

Thursday, February 14, 2013

• Breckenridge Pharmaceutical Inc., of Boca Raton, Fla., said the FDA granted approval of Pioglitazone Hydrochloride tablets, which is being manufactured and supplied by Synthon Pharmaceuticals Inc., and will be available in 15-mg, 30-mg, and 45-mg strengths.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription